Comparative analysis of adipose-, bone marrow-, and amniotic membrane-derived MSC secretomes and EVs reveals shared and source-specific therapeutic signatures for osteoarthritis
<b>Aim:</b> Mesenchymal stromal cells (MSCs) exert their therapeutic effects in osteoarthritis (OA) primarily through paracrine signaling, including secreted proteins and extracellular vesicle (EV)-associated microRNAs (miRNAs). However, the contribution of tissue origin to the composition and function of these secretomes remains unclear. This study aimed to provide a comprehensive molecular and functional comparison of secretomes from adipose-derived (ASCs), bone marrow-derived MSCs (BMSCs) and human amniotic membrane-derived MSCs, with a specific focus on OA-relevant pathways. <b>Methods:</b> MSCs were immunophenotyped by flow cytometry. Secretomes were profiled for 200 factors and 784 EV-miRNAs. Functional enrichment was performed using Gene Ontology and Reactome databases. <i>In vitro</i>, secretomes were tested on interleukin (IL)-1β-stimulated human chondrocytes to assess modulation of OA-related gene expression. <b>Results:</b> All MSC secretomes shared a core of factors enriched in anti-inflammatory and matrix-regulatory functions. ASCs showed the differential expression of a few modulators, potentially shifting their chondroprotective phenotype. EV-miRNAs further distinguished the MSC types. ASCs and BMSCs clustered closely in both overall miRNA content and functional enrichment, which included pathways for extracellular matrix organization, angiogenesis and IL-6 signaling. BMSC- and ASC-EVs had a higher ratio of OA-protective to destructive miRNAs, including miR-24-3p, miR-125b-5p and miR-222-3p. Functional assays confirmed that all MSC secretomes were effective in suppressing key OA-related genes in inflamed chondrocytes, with ASCs and BMSCs having a stronger activity. <b>Conclusion:</b> These findings support the development of MSC-derived cell-free therapies and emphasize the importance of molecular profiling in MSC source selection. Further studies are warranted to validate these observations and optimize MSC-based interventions for clinical translation in OA.
Authors
- Pietro Romele (ORCID: https://orcid.org/0000-0003-0721-3300)
- Paola De Luca (ORCID: https://orcid.org/0000-0001-9810-8818)
- Elsa Vertua
- Michela Taiana (ORCID: https://orcid.org/0000-0001-8257-8831)
- Giulio Grieco (ORCID: https://orcid.org/0009-0004-4716-1984)
- Laura De Girolamo
- Enrico Ragni
- Andrea Papait
- Antonietta Rosa Silini
- Ornella Parolini
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Casa Sollievo della Sofferenza (IT)
- Agostino Gemelli University Polyclinic (IT)
- Istituto Clinico Sant'Ambrogio (IT)
- IRCCS Ospedale Galeazzi - Sant'Ambrogio (IT)
- Fondazione Poliambulanza Istituto Ospedaliero (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Extracellular Vesicles and Circulating Nucleic Acids
- Published
- 2025-12-30
- DOI
- https://doi.org/10.20517/evcna.2025.115
- Primary Topic
- Osteoarthritis Treatment and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00